CEO Venkateswarlu Nelabhotla to discuss novel and unique pipeline targeting antimicrobial resistant ...View More
Vyome announced completion of patient enrollment for Proof of Concept Study for VB 1953 for treatmen...View More
Vyome announced top-line data from its phase 1 clinical trial evaluating VB-1953, a topically admini...View More
Co-Founder & CEO of Vyome Biosciences N. Venkat talks to Economic Times about how Vyome is developin...View More
Copyright © 2015 Vyome Biosciences. All rights reserved.